Connection
Matthew Ellis to Delayed-Action Preparations
This is a "connection" page, showing publications Matthew Ellis has written about Delayed-Action Preparations.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.214 |
|
|
|
-
Iwanicki JL, Severtson SG, McDaniel H, Rosenblum A, Fong C, Cicero TJ, Ellis MS, Kurtz SP, Buttram ME, Dart RC. Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States. PLoS One. 2016; 11(12):e0167499.
Score: 0.117
-
Jewell JS, Rockhill KM, Burkett H, Black JC, Ellis MS, Dart R. Trends in XTAMPZA ER and other oxycodone misuse and abuse during COVID-19: A mosaic approach. J Opioid Manag. 2025 May-Jun; 21(3):249-259.
Score: 0.052
-
Jewell J, Black J, Ellis M, Olsen H, Iwanicki J, Dart R. A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population. Clin Drug Investig. 2023 Mar; 43(3):197-203.
Score: 0.045